Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2057-3804
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment ; volume:8 ; number:1 ; day:12 ; month:5 ; year:2022 ; pages:1-9 ; date:12.2022
Cardio-Oncology ; 8, Heft 1 (12.5.2022), 1-9, 12.2022
- Creator
-
Delavar, Arash
Boutros, Catherine
Barnea, Dana
MD, Wendy L. Schaffer
Tonorezos, Emily S.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40959-022-00138-x
- URN
-
urn:nbn:de:101:1-2022071719223439015151
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Delavar, Arash
- Boutros, Catherine
- Barnea, Dana
- MD, Wendy L. Schaffer
- Tonorezos, Emily S.
- SpringerLink (Online service)
Other Objects (12)
Correction: Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Electrocardiograms for cardiomyopathy risk stratification in children with anthracycline exposure
Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese Community
Sexual Issues in Treating Trauma Survivors
Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy
Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysis
Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks
Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy
Correction: Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Electrocardiograms for cardiomyopathy risk stratification in children with anthracycline exposure
Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese Community
Sexual Issues in Treating Trauma Survivors
Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy
Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysis
Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks
Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy
Correction: Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Electrocardiograms for cardiomyopathy risk stratification in children with anthracycline exposure
Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese Community
Sexual Issues in Treating Trauma Survivors
Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy
Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysis
Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks
Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy